Trial · NCT01190098
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Epworth Sleepiness Scale Score From Baseline to Visit 4 | Lacosamide | -1.2 | 95% Confidence Interval -2.9 to 0.53 | Units on a scale | |
| Change in Epworth Sleepiness Scale Score From Baseline to Visit 4 | Sugar Pill | -1.1 | 95% Confidence Interval -5.2 to 3.0 | Units on a scale | |
| Change in the Fatigue Severity Scale From Baseline to Visit 4. | Lacosamide | 0.30 | 95% Confidence Interval -3.7 to 4.3 | units on a scale | |
| Change in the Fatigue Severity Scale From Baseline to Visit 4. | Sugar Pill | -5.4 | 95% Confidence Interval -17.1 to 6.4 | units on a scale | |
| Change in Pittsburgh Sleep Quality Inventory (PSQI) From Baseline to Visit 4 | Lacosamide | -1.6 | 95% Confidence Interval -2.9 to 0.0 | units on a scale | |
| Change in Pittsburgh Sleep Quality Inventory (PSQI) From Baseline to Visit 4 | Sugar Pill | -1.3 | 95% Confidence Interval -2.9 to 0.3 | units on a scale | |
| Change in Functional Outcomes of Sleep Questionnaire (FOSQ) From Baseline to Visit 4. | Lacosamide | 0.3 | 95% Confidence Interval 0.0 to 1.0 | units on a scale | |
| Change in Functional Outcomes of Sleep Questionnaire (FOSQ) From Baseline to Visit 4. | Sugar Pill | 1.1 | 95% Confidence Interval -1.3 to 3.5 | units on a scale | |
| Change in Adverse Event Profile (AEP) From Baseline to Visit 4. | Lacosamide | -1.2 | 95% Confidence Interval -5.2 to 2.9 | units on a scale | |
| Change in Adverse Event Profile (AEP) From Baseline to Visit 4. | Sugar Pill | -6.0 | 95% Confidence Interval -14.2 to 2.2 | units on a scale | |
| Change in Patient Health Questionnaire-9 (PHQ-9) From Baseline to Visit 4. | Lacosamide | -1.1 | 95% Confidence Interval -2.7 to 0.6 | units on a scale | |
| Change in Patient Health Questionnaire-9 (PHQ-9) From Baseline to Visit 4. | Sugar Pill | -1.2 | 95% Confidence Interval -4.6 to 2.1 | units on a scale | |
| Change in Daily Seizure Frequency From Baseline to Visit 4 | Lacosamide | 0.0 | Inter-Quartile Range 0.0 to 0.15 | number of seizures per day | |
| Change in Daily Seizure Frequency From Baseline to Visit 4 | Sugar Pill | 0.0 | Inter-Quartile Range 0.0 to 0.04 | number of seizures per day | |
| Change in Quality of Life in Epilepsy (QOLIE-31) From Baseline to Visit 4 | Lacosamide | 4.0 | 95% Confidence Interval 1.2 to 6.7 | units on a scale | |
| Change in Quality of Life in Epilepsy (QOLIE-31) From Baseline to Visit 4 | Sugar Pill | 4.2 | 95% Confidence Interval -2.3 to 10.6 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01190098/results